TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.

Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.

Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.

We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.

BNP Paribas

Bpifrance

CM-CIC Capital Prive

Sofinnova Partners

European Investment Fund

Omnes Capital

Karista

Cathay Capital

Cathay Health

Crédit Mutuel Innovation

Mérieux Equity Partners

Merieux Developpement

Fonds Stratégique d'Investissement

IBD Ventures

TISSIUM

Mölnlycke France is a competitor of TISSIUM in the medical technology sector, offering solutions for tissue reconstruction.

Mölnlycke France

GMED is a competitor of TISSIUM in the medical technology sector, providing products and solutions for tissue reconstruction.

GMED

SURGIVISIO competes with TISSIUM in the medical technology sector, offering solutions for tissue reconstruction.

SURGIVISIO

Johnson & Johnson is a major player in the medical devices industry, with innovation areas that may overlap with tissue reconstruction and implants.

Johnson & Johnson

Medtronic is a leading company in the medical devices industry, with potential innovation areas related to tissue reconstruction and implants.

Medtronic

Geistlich Pharma is involved in the innovation of tissue reconstruction implants and may compete with TISSIUM in this area.

Geistlich Pharma

Albemarle is a company with innovation areas that may intersect with tissue reconstruction and implants in the medical devices industry.

Albemarle

EW Healthcare Partners is an investment firm that may have interests in companies related to tissue reconstruction and implants in the medical devices industry.

EW Healthcare Partners

B. Braun is a company with activities in the medical devices industry, potentially including innovation areas related to tissue reconstruction and implants.

B. Braun

Tissium is a biotechnology company focused on the development of biomorphic programmable polymers for tissue reconstruction. Their approach aims to provide solutions that mimic the native environment of tissues, potentially revolutionizing the field of regenerative medicine.

Tissium

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

financial_statements

network_onboarding

company_summary

signals

regulatory_analysis

industry_analysis

swot_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

news_advanced

news_impact_assignment_advanced

news_processing_advanced

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 14, 2024 7:37 AM	a34ecc5f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
news advanced	general
news impact assignment advanced	general
news processing advanced	general
peers	general
news basic	general
events	markdown
bundesanzeiger	filings
financial statements	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
swot analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
customer profile	customers

COM:TISSIUM

Tissium